medline.ch Gastroenterologie Leber Leberzirrhose

	Assessing clinical outcomes in cirrhotic patients with thromboembolic complications. Eur J Gastroenterol Hepatol Banks MC, Ahanotu A, Lee KJ, Abougergi M. PMID: 42664454 [PubMed - indexed for MEDLINE]
	Prognostic value of different sarcopenia assessment methods for mortality in patients with liver cirrhosis: a systematic review and meta-analysis. Front Nutr Xie W, Shi W, Xu R, Shang Z, Huo G, Zhang Z, Yang Z. PMID: 42661677 [PubMed]
	E3 Ubiquitin Ligases in MASH-Associated Liver Fibrosis: Mechanisms and Therapeutic Opportunities. Liver Int Oh AR, Jeong Y, Jung YH, Kim YU, Gi H, Kim DW, Choi YD, Lee SB, Kim K. PMID: 42661460 [PubMed - indexed for MEDLINE]
	A Computerized Clinical Decision Support Tool Increases Rates of Confirmatory Testing in MASLD Patients at Risk for Advanced Fibrosis. J Am Board Fam Med Xiao T, Miller J, Rowland B, Bundy R, Moses A, Witek L, Obermiller C, Dharod A, Rudnick S. PMID: 42660653 [PubMed - indexed for MEDLINE]
	Noninvasive Detection of Clinically Significant Fibrosis in Biopsy-Proven MASLD: A Retrospective Cross-Sectional Diagnostic Accuracy Study. Medicina (Kaunas) Eksi O, Atay K, Eskazan T, Abishov E, Canbakan M, Canbakan B. PMID: 42654424 [PubMed - indexed for MEDLINE]
	Point-of-Care Ultrasound Assessment of Pulmonary and Venous Congestion in Patients with Liver Cirrhosis and Acute Kidney Injury Receiving Albumin: An Exploratory Prospective Study from a Resource-Limited Tertiary Care Center in Western Mexico. Medicina (Kaunas) Rubio-Mora BR, Ochoa-Rodríguez MA, Ambriz-Alarcón MA, Lozano-Sabido EA, Meugniot-García H, Jiménez-Pérez DM, Calleros-Camarena ÁI, Ramírez-Ochoa S, Vicente-Hernández B, Cervantes-Guevara G, Rabago-Solorio E, Cervantes-Perez E. PMID: 42654357 [PubMed - indexed for MEDLINE]
	Therapeutic Targets for Hepatic Fibrosis Driven by Hypoxia-Mediated Hepatic Stellate Cell Activation. Biomolecules Li W, Li T, Mao J. PMID: 42650757 [PubMed - indexed for MEDLINE]
	ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial. Lancet Gastroenterol Hepatol Loomba R, Wang S, Desai D, Santillano D, Lucas KJ, Neff G, Bianco AC, Bruinstroop E, Su Y, Achneck HE, Le K, Fitzgerald M, Wu M, Lin TI, Chanda SM, Blatt LM, Mantzoros CS. PMID: 42648297 [PubMed - as supplied by publisher]
	Targeting PPAR-Regulated Pathways to Treat Cholestatic Liver Diseases: Novel Applications of Liquid Biopsies. Cells Hayes CM, Cross DR, Achour B, Ghonem NS. PMID: 42645170 [PubMed - indexed for MEDLINE]
	Clinical Trial: Intensive Supervised Nutritional Therapy Versus Guideline-Based Nutritional Advice for Sarcopenia in Decompensated Cirrhosis-A Randomised Controlled Trial. Aliment Pharmacol Ther Dhaked GK, Sharma PN, Sharma KK, Maharshi S, Agrawal S, Pokharna R, Nijhawan S, Sharma SS. PMID: 42643064 [PubMed - as supplied by publisher]
	Portal Vein Thrombosis Risk in Cirrhotic Patients With Portal Hypertension on Beta-Blockers: A Multi-Institutional Cohort Study. Liver Int Abosheaishaa H, Elfert K, Abusuliman M, Ismail A, Olimy A, Alzamzamy AE, Omran A, Rizzo V, Nassar M, El-Kassas M. PMID: 42642993 [PubMed - indexed for MEDLINE]
	Risk stratification of non-acute decompensation in alcohol-related cirrhosis using the red cell distribution width-to-platelet ratio. Dig Liver Dis Romeo M, Domislovi, Di Nardo F, Napolitano C, Vaia P, Basile C, Mrzljak A, Federico A, Dallio M. PMID: 42642231 [PubMed - as supplied by publisher]
	Association between thyroid feedback quartile index and FIB-4-defined fibrosis risk in patients with metabolic dysfunction-associated steatotic liver disease, type 2 diabetes mellitus, and treated primary hypothyroidism: an exploratory cross-sectional study. Front Endocrinol (Lausanne) Wang Y, Xie J, Wang Y, Liu X, Zhou X. PMID: 42638674 [PubMed - indexed for MEDLINE]
	Meta-Analysis: Enhanced Liver Fibrosis (ELF) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. Aliment Pharmacol Ther Gee MFW, Chalfin DB, De Vol EB, Levy HR, Boltyenkov AT, Casale MG, Sanyal AJ. PMID: 42638152 [PubMed - as supplied by publisher]
	Current intervention strategies for collateral circulation formation and splenomegaly in portal hypertension due to cirrhosis. Digestion Sun Y, Zhao Y, Zhao B, Xu Y, Chu H. PMID: 42636178 [PubMed - as supplied by publisher]
	Fibrosis in One-Year Protocol Biopsies After Liver Transplantation Is Associated With Graft Loss: A Multicenter Cohort Study. APMIS Akdag D, Rostved AA, Rasmussen A, Willemoe GL, Chiranth D, Ericzon BG, Jorns C, Bennet W, Nordin A, Åberg F, Hillingsø JG, Nielsen SD, Pommergaard HC. PMID: 42635025 [PubMed - indexed for MEDLINE]
	A Retrospective Analysis of 581 Cases of Esophagogastric Variceal Bleeding Complicated by Portal Vein Thrombosis at a Single Center. Can J Gastroenterol Hepatol Zhang J, He Y, Wu S, Kong D. PMID: 42634416 [PubMed - indexed for MEDLINE]
	Cirrhosis Risk in Sarcoidosis Without Documented Hepatic Involvement-A Large Nationwide Population-Based Cohort Study. Liver Int Shani U, Davidov Y, Zigmond E, Ben-Ami T, Regev O, Cohen AD, Amital H, Ben-Shabat N. PMID: 42631401 [PubMed - indexed for MEDLINE]
	Well-established efficacy of camrelizumab combined with radiofrequency ablation in cirrhotic patients with hepatic cancer. Am J Transl Res Shi L, He X, Hu Y, Rong Y, Xi J. PMID: 42631165 [PubMed]
	[Translated article] Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis. Farm Hosp Rodríguez Esquíroz A, Garjón Parra J, Echeverría Gorriti A, Sanz Álvarez L, Marín Marín M, Aguinaga Ontoso I. PMID: 42629217 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 39183

Seite 1 von 1960

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung